4.6 Article

Tafolecimab: First Approval

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Salim S. Virani et al.

Summary: The 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease updates and consolidates previous guidelines and provides evidence-based approaches to patient management, taking into account social determinants of health and emphasizing shared decision-making and team-based care. It covers various aspects, including treatment decisions, symptom reduction, revascularization, special populations, follow-up and monitoring, evidence gaps, and areas for future research.

CIRCULATION (2023)

Review Medicine, Research & Experimental

PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes

Connie N. Hess et al.

ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)